Trial Profile
A retrospective study to evaluate the effect of Everolimus and Cyclosporine in kidney-transplanted patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 28 Apr 2016 New trial record
- 01 Mar 2016 Results (n=26) published in the Transplantation Proceedings.